合成α-羟基托酚酮对ANT(2")-Ia耐药酶的抑制作用及氨基糖苷类抗生素活性的恢复
Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones.
作者信息
Hirsch Danielle R, Cox Georgina, D'Erasmo Michael P, Shakya Tushar, Meck Christine, Mohd Noushad, Wright Gerard D, Murelli Ryan P
机构信息
Department of Chemistry, Brooklyn College, The City University of New York, 2900 Bedford Avenue, Brooklyn, NY 11210, United States; Department of Chemistry, The Graduate Center, The City University of New York, 365 Fifth Avenue, New York, NY 10016, United States.
M. G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, ON L8N 4K1, Canada.
出版信息
Bioorg Med Chem Lett. 2014 Nov 1;24(21):4943-7. doi: 10.1016/j.bmcl.2014.09.037. Epub 2014 Sep 19.
Abstract
Aminoglycoside-2"-O-nucleotidyltransferase ANT(2")-Ia is an aminoglycoside resistance enzyme prevalent among Gram-negative bacteria, and is one of the most common determinants of enzyme-dependant aminoglycoside-resistance. The following report outlines the use of our recently described oxidopyrylium cycloaddition/ring-opening strategy in the synthesis and profiling of a library of synthetic α-hydroxytropolones against ANT(2")-Ia. In addition, we show that two of these synthetic constructs are capable of rescuing gentamicin activity against ANT-(2")-Ia-expressing bacteria.
摘要
氨基糖苷2″-O-核苷酸转移酶ANT(2″)-Ia是一种在革兰氏阴性菌中普遍存在的氨基糖苷抗性酶，是酶依赖性氨基糖苷抗性最常见的决定因素之一。以下报告概述了我们最近描述的氧化吡啶鎓环加成/开环策略在合成针对ANT(2″)-Ia的合成α-羟基托酚酮文库及其分析中的应用。此外，我们表明这些合成构建体中的两种能够恢复庆大霉素对表达ANT-(2″)-Ia的细菌的活性。
相似文献
1
Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones.合成α-羟基托酚酮对ANT(2")-Ia耐药酶的抑制作用及氨基糖苷类抗生素活性的恢复
Bioorg Med Chem Lett. 2014 Nov 1;24(21):4943-7. doi: 10.1016/j.bmcl.2014.09.037. Epub 2014 Sep 19.
2
Structural and molecular basis for resistance to aminoglycoside antibiotics by the adenylyltransferase ANT(2″)-Ia.腺苷酸转移酶ANT(2″)-Ia对氨基糖苷类抗生素耐药的结构和分子基础。
mBio. 2015 Jan 6;6(1):e02180-14. doi: 10.1128/mBio.02180-14.
3
New inhibitors for aminoglycoside-adenylyltransferase.氨基糖苷腺苷酸转移酶的新型抑制剂
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;270(1-2):66-75. doi: 10.1016/s0176-6724(88)80142-1.
4
7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase.7-羟基托酚酮：一种氨基糖苷-2″-O-腺苷酰转移酶抑制剂。
Antimicrob Agents Chemother. 1982 Nov;22(5):824-31. doi: 10.1128/AAC.22.5.824.
5
Relation between aminoglycoside 2"-O-nucleotidyltransferase activity and aminoglycoside resistance.氨基糖苷2”-O-核苷酸基转移酶活性与氨基糖苷耐药性之间的关系
Antimicrob Agents Chemother. 1984 Feb;25(2):234-7. doi: 10.1128/AAC.25.2.234.
6
ANT(9)-Ic, a Novel Chromosomally Encoded Aminoglycoside Nucleotidyltransferase from Brucella intermedia.中间布鲁氏菌中新型染色体编码氨基糖苷核苷转移酶 ANT(9)-Ic。
Microbiol Spectr. 2023 Jun 15;11(3):e0062023. doi: 10.1128/spectrum.00620-23. Epub 2023 Apr 11.
7
Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.在西班牙分离的耐阿莫西林/克拉维酸的临床大肠杆菌分离株中氨基糖苷类修饰酶的分子鉴定。
Int J Antimicrob Agents. 2015 Aug;46(2):157-63. doi: 10.1016/j.ijantimicag.2015.03.008. Epub 2015 Apr 29.
8
Structural Analysis of the Tobramycin and Gentamicin Clinical Resistome Reveals Limitations for Next-generation Aminoglycoside Design.妥布霉素和庆大霉素临床耐药基因组的结构分析揭示了下一代氨基糖苷类药物设计的局限性。
ACS Chem Biol. 2016 May 20;11(5):1339-46. doi: 10.1021/acschembio.5b01070. Epub 2016 Mar 4.
9
Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance.结构导向的蛋白激酶抑制剂优化可逆转氨基糖苷类抗生素耐药性。
Biochem J. 2013 Sep 1;454(2):191-200. doi: 10.1042/BJ20130317.
10
The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.在中国，大肠埃希菌中主要的氨基糖苷类修饰酶 AAC(3)-II 导致其对庆大霉素和阿米卡星的耐药性存在显著差异。
Microb Drug Resist. 2012 Feb;18(1):42-6. doi: 10.1089/mdr.2010.0190. Epub 2011 Nov 8.
引用本文的文献
1
The Evolution of Cell Culture Systems to Study Hepatitis B Virus Pathogenesis and Antiviral Susceptibility.用于研究乙型肝炎病毒发病机制和抗病毒敏感性的细胞培养系统的演变
Viruses. 2025 Jul 29;17(8):1057. doi: 10.3390/v17081057.
2
The Global Challenge of : Antimicrobial Resistance and Emerging Intervention Strategies.《全球挑战：抗菌药物耐药性与新兴干预策略》
Trop Med Infect Dis. 2025 Jan 16;10(1):25. doi: 10.3390/tropicalmed10010025.
3
Intermolecular Oxidopyrylium (5 + 2) Cycloaddition/Reductive Ring-Opening Strategy for the Synthesis of α-Methoxytropones.用于合成α-甲氧基环庚三烯酚酮的分子间氧化吡啶鎓（5 + 2）环加成/还原开环策略
J Org Chem. 2024 Dec 6;89(23):17813-17817. doi: 10.1021/acs.joc.4c01989. Epub 2024 Nov 12.
4
Healthcare Equipment and Personnel Reservoirs of Carbapenem-Resistant Epidemic Clones in Intensive Care Units in a Tunisian Hospital.突尼斯一家医院重症监护病房中耐碳青霉烯类流行克隆的医疗设备及人员储存库
Microorganisms. 2023 Oct 26;11(11):2637. doi: 10.3390/microorganisms11112637.
5
Catch me if you can: capturing microbial community transformation by extracellular DNA using Hi-C sequencing.见招拆招：利用 Hi-C 测序技术捕捉胞外 DNA 介导的微生物群落转化。
Antonie Van Leeuwenhoek. 2023 Jul;116(7):667-685. doi: 10.1007/s10482-023-01834-z. Epub 2023 May 8.
6
Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance.抗生素佐剂：对抗抗生素耐药性的通用方法。
ACS Omega. 2023 Mar 14;8(12):10757-10783. doi: 10.1021/acsomega.3c00312. eCollection 2023 Mar 28.
7
The role of adjuvants in overcoming antibacterial resistance due to enzymatic drug modification.佐剂在克服因酶促药物修饰导致的抗菌耐药性方面的作用。
RSC Med Chem. 2022 Sep 22;13(11):1276-1299. doi: 10.1039/d2md00263a. eCollection 2022 Nov 16.
8
Metal coordinating inhibitors of Rift Valley fever virus replication.金属配位抑制剂抑制裂谷热病毒复制。
PLoS One. 2022 Sep 16;17(9):e0274266. doi: 10.1371/journal.pone.0274266. eCollection 2022.
9
Aminoglycoside-Modifying Enzymes Are Sufficient to Make Clinically Resistant to Key Antibiotics.氨基糖苷类修饰酶足以使临床菌株对关键抗生素产生耐药性。
Antibiotics (Basel). 2022 Jul 1;11(7):884. doi: 10.3390/antibiotics11070884.
10
Synthesis of Polyoxygenated Tropolones and their Antiviral Activity against Hepatitis B Virus and Herpes Simplex Virus-1.多氧化三酮的合成及其抗乙型肝炎病毒和单纯疱疹病毒-1的活性。
Chemistry. 2022 Feb 21;28(10):e202104112. doi: 10.1002/chem.202104112. Epub 2022 Jan 31.
本文引用的文献
1
The biology and synthesis of α-hydroxytropolones.α-羟基环庚三烯酚酮的生物学与合成
Medchemcomm. 2014 Jul 1;5(7):842-852. doi: 10.1039/C4MD00055B.
2
Prospects for new antibacterials: can we do better?新型抗菌药物的前景：我们能否做得更好？
Expert Opin Investig Drugs. 2014 Feb;23(2):145-8. doi: 10.1517/13543784.2014.847087. Epub 2013 Nov 11.
3
Triflic acid-mediated rearrangements of 3-methoxy-8-oxabicyclo[3.2.1]octa-3,6-dien-2-ones: synthesis of methoxytropolones and furans.三氟乙酸介导的 3-甲氧基-8-氧杂双环[3.2.1]辛-3,6-二烯-2-酮的重排反应：甲氧基色酮和呋喃的合成。
J Org Chem. 2013 Dec 6;78(23):11707-13. doi: 10.1021/jo401617r. Epub 2013 Nov 14.
4
Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.用于预测 HIV-1 RT 相关 RNase H 抑制的虚拟筛选模型。
PLoS One. 2013 Sep 16;8(9):e73478. doi: 10.1371/journal.pone.0073478. eCollection 2013.
5
Transient kinetic analyses of the ribonuclease H cleavage activity of HIV-1 reverse transcriptase in complex with efavirenz and/or a β-thujaplicinol analogue.HIV-1 逆转录酶与依非韦伦和/或β-雪松醇类似物复合物的核糖核酸酶 H 切割活性的瞬态动力学分析。
Biochem J. 2013 Oct 15;455(2):179-84. doi: 10.1042/BJ20130850.
6
Antibiotic resistance: the last resort.抗生素耐药性：最后的手段。
Nature. 2013 Jul 25;499(7459):394-6. doi: 10.1038/499394a.
7
β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.β-雪松醇通过阻断病毒核糖核酸酶 H 的活性抑制乙型肝炎病毒复制。
Antiviral Res. 2013 Sep;99(3):221-9. doi: 10.1016/j.antiviral.2013.06.007. Epub 2013 Jun 21.
8
Phosphoryl transfer by protein kinase A is captured in a crystal lattice.蛋白激酶 A 的磷酸化转移被捕捉在晶格中。
J Am Chem Soc. 2013 Mar 27;135(12):4788-98. doi: 10.1021/ja312237q. Epub 2013 Mar 12.
9
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.乙型肝炎病毒核糖核酸酶 H 对人类免疫缺陷病毒核糖核酸酶 H 和整合酶酶的抑制剂敏感。
PLoS Pathog. 2013 Jan;9(1):e1003125. doi: 10.1371/journal.ppat.1003125. Epub 2013 Jan 22.
10
An oxidopyrylium cyclization/ring-opening route to polysubstituted α-hydroxytropolones.通过氧化吡喃鎓环化/开环反应构建多取代的α-羟色酮。
Org Lett. 2012 Dec 7;14(23):5988-91. doi: 10.1021/ol302892g. Epub 2012 Nov 20.
Zotero 插件